| Global Epidemiology of Tuberculosis |
39 |
| Pathogenesis of Acute Respiratory Distress Syndrome |
21 |
| Prone Positioning in Acute Respiratory Distress Syndrome |
20 |
| Epidemiology of Nontuberculous Mycobacteriosis |
16 |
| Alveolar Hemorrhage in Vasculitis (Primary and Secondary) |
12 |
| Pulmonary Complications of Systemic Lupus Erythematosus |
11 |
| Acute Respiratory Distress Syndrome Phenotypes |
9 |
| Exercise and Asthma |
9 |
| Primary Graft Dysfunction (PGD) Following Lung Transplantation |
8 |
| Antineutrophil Cytoplasmic Antibody-Associated Lung Fibrosis |
8 |
| Geographic Distribution of Nontuberculous Mycobacteria Isolated from Clinical Specimens: A Systematic Review |
8 |
| Treatment of Mycobacterium avium Complex (MAC) |
7 |
| Chronic Lung Allograft Dysfunction: Evolving Concepts and Therapies |
6 |
| Pulmonary and Bronchiolar Involvement in Sjogren's Syndrome |
6 |
| Nontuberculous Mycobacteria in Cystic Fibrosis |
6 |
| Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss) |
6 |
| Granulomatosis with Polyangiitis (Wegener's Granulomatosis): Evolving Concepts in Treatment |
6 |
| Treating the Underlying Cystic Fibrosis Transmembrane Conductance Regulator Defect in Patients with Cystic Fibrosis |
6 |
| Management of Multidrug-Resistant Tuberculosis |
5 |
| Microbiology of Cystic Fibrosis Airway Disease |
5 |
| Management and Prevention of Central Venous Catheter-Related Infections in the ICU |
5 |
| How Should Lungs Be Allocated for Transplant? |
5 |
| Acute on Chronic Liver Failure and Immune Dysfunction: A Mimic of Sepsis |
5 |
| Emerging Role of Extracorporeal Support in Acute and Acute-on-Chronic Liver Failure: Recent Developments |
5 |
| Tracheobronchomalacia and Excessive Dynamic Airway Collapse: Medical and Surgical Treatment |
5 |
| Thoracoscopy: Advances and Increasing Role for Interventional Pulmonologists |
5 |
| Diagnosis and Management of Severe Asthma |
5 |
| Influenza Infections and Emergent Viral Infections in Intensive Care Unit |
5 |
| The Human Respiratory Microbiome: Implications and Impact |
5 |
| Acute Cellular Rejection: Is It Still Relevant? |
5 |
| Multidisciplinary Evaluation in Patients with Lung Disease Associated with Connective Tissue Disease |
4 |
| Surveillance Bronchoscopy: Is It Still Relevant? |
4 |
| Cystic Fibrosis: Pathophysiology of Lung Disease |
4 |
| Adult Care in Cystic Fibrosis |
4 |
| Pathogenesis of ANCA-Associated Pulmonary Vasculitis |
4 |
| Microscopic Polyangiitis: New Insights into Pathogenesis, Clinical Features and Therapy |
4 |
| Malignant Mesothelioma: Has Anything Changed? |
4 |
| Pathophysiology and Management of Acute Respiratory Distress Syndrome in Obese Patients |
4 |
| Fluid Management in Acute Respiratory Distress Syndrome |
4 |
| Prevention of Intensive Care Unit-Acquired Pneumonia |
4 |
| Controlling the Diffusion of Multidrug-Resistant Organisms in Intensive Care Units |
4 |
| Airway Inflammation and Inflammatory Biomarkers |
4 |
| Advances and Evolving Concepts in Allergic Asthma |
4 |
| Cystic Fibrosis Diagnosis in Newborns, Children, and Adults |
4 |
| Nontuberculous Mycobacteria in Cystic Fibrosis |
3 |
| Biologic Therapy and Asthma |
3 |
| Management of Asthma during Pregnancy: Optimizing Outcomes and Minimizing Risk |
3 |
| Respiratory Viruses and Asthma |
3 |
| Environmental Causes of Asthma |
3 |
| Perioperative Considerations in Liver Transplantation |
3 |
